When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JAZZ - FDA OKs Jazz Pharma's Xywav for cataplexy in narcolepsy patients
Jazz Pharmaceuticals plc
The FDA has approved Jazz Pharmaceuticals' (NASDAQ:JAZZ) Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution for the treatment of cataplexy (excessive daytime sleepiness) in patients at least seven year old with narcolepsy.
More news on: Jazz Pharmaceuticals plc, Healthcare stocks news,